-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Hoth Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q2 2024.
- Hoth Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $13.4K.
- Hoth Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $28.7K.
- Hoth Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$153K, a 50% increase from 2022.
- Hoth Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$306K, a 44.3% decline from 2021.
- Hoth Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$212K, a 304% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)